The Schenergix HME A20 is designed for high-capacity commercial-scale pharmaceutical and nutraceutical manufacturing. Hot Melt Extrusion is a continuous process that has become essential for improving drug solubility, bioavailability, and controlled release profiles. The A20 also supports both wet and dry granulation using HME, giving manufacturers the flexibility to develop a wider range of formulations.
Combining performance, flexibility, and reliability, the A20 is a trusted choice for large-scale production environments. With convertible barrel lengths and a throughput of up to 15 kg/h, it enables efficient, solvent-free processing. Its advanced screw design, coupled with precise heating and cooling controls, ensures consistent product quality and scalability. Built with safety and compliance in mind, the A20 can be supplied with flexible or rigid isolators, meeting the highest containment standards.
Key Features include:
